Dnatrix, Inc.
Records under this name other than patents Dnatrix, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,238,698 | Biomarkers and Combination Therapies Using Oncolytic Virus and Immunomodulation now held by CV Biomanufacturing, LLC In force · High confidence | In force | High confidence | |
| US 11,065,285 | Biomarkers and Combination Therapies Using Oncolytic Virus and Immunomodulation now held by CV Biomanufacturing, LLC In force · Medium confidence | In force | Medium confidence | |
| US 11,090,344 | Adenovirus and Immunomodulator Combination Therapy now held by CV Biomanufacturing, LLC In force · High confidence | In force | High confidence | |
| US 11,110,137 | Combination Therapy for Treatment of Brain Cancers now held by CV Biomanufacturing, LLC In force · Medium confidence | In force | Medium confidence | |
| US 10,016,470 | Oncolytic Adenoviruses for Cancer Treatment Lapsed on the fee record Ended Jul 10, 2022 · High confidence | Lapsed on the fee record | Ended Jul 10, 2022 | High confidence |
| 12/184,881 | Oncolytic Adenoviruses for Cancer Treatment Abandoned Abandoned Jul 28, 2014 | Abandoned | Abandoned Jul 28, 2014 | |
| 14/327,840 | Oncolytic Adenoviruses for Cancer Treatment Abandoned Abandoned Jun 13, 2016 | Abandoned | Abandoned Jun 13, 2016 | |
| 14/899,360 | Treatment of Brain Cancer with Oncolytic Adenovirus now held by CV Biomanufacturing, LLC Abandoned Abandoned Aug 13, 2021 | Abandoned | Abandoned Aug 13, 2021 | |
| 15/038,446 | Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s) now held by CV Biomanufacturing, LLC Abandoned Abandoned Aug 21, 2018 | Abandoned | Abandoned Aug 21, 2018 | |
| 16/020,738 | Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(S) now held by CV Biomanufacturing, LLC Abandoned Abandoned Mar 15, 2022 | Abandoned | Abandoned Mar 15, 2022 |